Table 4 Associations between statin use with primary and second endpoints in propensity-matched cohort and multivariable-adjusted overall cohorts of patients hospitalized with COVID-19.

From: Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19

Ā 

OR

95% CI

Primary endpoint—In-hospital mortality within 30 days

PS-matched

0.47

0.36–0.62

Multivariable (PS-matched)

0.48

0.35–0.65

Multivariable (overall)

0.49

0.38–0.63

Secondary endpoint – Invasive mechanical ventilation within 30 days

Ā PS-matched

0.76

0.58–1.00

Ā Multivariable (PS-matched)

0.89

0.68–1.2

Ā Multivariable (overall)

0.80

0.64–1.02

  1. CI confidence interval, OR odds ratio, PS propensity scoring.